Minimally invasive implantable neurostimulation system

Patent metadata

Field	Value
Publication number	US-11957893-B2
Application number	US-202016947944-A
Country	US
Kind code	B2
Filing date	Aug 25, 2020
Priority date	Dec 7, 2012
Publication date	Apr 16, 2024
Grant date	Apr 16, 2024

Abstract

A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.

First claim

The invention claimed is:

1. A minimally invasive implantable tibial nerve stimulation device, comprising:
an enclosure constructed of at least one of a biocompatible titanium or stainless steel,
the enclosure formed as a single tube having a circular cross-section with an overall length of less than about thirty millimeters and a total volume of less than about one cubic centimeter to enable minimally invasive implantation of the enclosure within a body of a patient;
a power supply;
device electronics within the enclosure including:
a pulse generating circuit;
a control unit; and
memory, the memory including memory-readable instructions that when executed by the control unit cause the pulse generating circuit of the minimally invasive implantable tibial nerve stimulation device to deliver a nerve stimulation therapy to the tibial nerve of the patient,

wherein operation of the minimally invasive implantable tibial nerve stimulation device is selectively adjustable via an external magnetic field; and
a telemetry module within the enclosure,
the telemetry module configured to enable communication with at least one external programming device, wherein communication with the external programming device enables receipt of a command to adjust an intensity or strength of the therapy up or down,
wherein communication with the device electronics is confirmable by the external programming device; and

an insulative outer coating at least partially surrounding the hermetically sealed enclosure and configured to protect the enclosure and to reduce patient discomfort; and
an insulated lead including:
a proximal end configured to be connected to an electrically insulated, sealed header located on one end of the enclosure, and
a distal end including two or more electrodes in electrical communication with the device electronics, the two or more electrodes spaced apart from one another and constructed of at least one of a conductive platinum or platinum iridium material,

wherein the lead is configured to be positioned to the tibial nerve of a patient for the delivery of the nerve stimulation therapy to the tibial nerve of the patient as a treatment for symptoms related to urinary incontinence or an overactive bladder.

2. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the implantable neural stimulation device has a total volume of between about one cubic centimeter and about one tenth of a cubic centimeter.

3. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the shape and profile of the housing is adapted for implantation at a particular implant site.

4. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the housing is configured for implantation in a region of the medial malleolus of a patient for delivering a neurostimulation therapy to a tibial nerve of the patient.

5. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the power supply comprises at least one of a primary battery cell, rechargeable battery cell, or an inductively coupled power source.

6. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the insulated lead has an overall length of less than about five centimeters.

7. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the insulative outer coating includes one or more fixation elements in the form of a tab defining an aperture through which a suture can be threaded to enable stable fixation of the tibial nerve stimulation device at an implant site.

8. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the lead includes a passive fixation member enabling tissue growth to anchor the at least one electrode at a targeted site.

9. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the telemetry module is configured to establish a wireless telemetry link over a distance of at least two-feet.

10. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the telemetry module is configured to enable a user to control therapy output parameters, including at least one of a pulse amplitude, a pulse width, pulse shape, pulse frequency, duty cycle, or therapy on and off times.

11. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the telemetry module is configured to at least one of transmit or receive at least one of patient data, therapy data or device related data.

12. The implantable neural stimulation device of claim 11 , wherein the telemetry module is configured to transmit a remaining life of the power supply.

13. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein an output of the pulse generating circuit is selectively adjustable via an external magnetic field.

14. The minimally invasive implantable tibial nerve stimulation device of claim 13 , wherein a decrease in the output of the pulse generating circuit results in a reduced power requirement.

15. The minimally invasive implantable tibial nerve stimulation device of claim 13 , wherein the external magnetic field is configured to cease the neuro stimulation therapy.

16. The minimally invasive implantable tibial nerve stimulation device of claim 1 , wherein the telemetry module of the minimally invasive implantable medical device is configured to provide confirmation to the external programming device upon receipt of a communication from the external programming device.

Assignees

• Medtronic Inc

Inventors

• Tischendorf Brad C
• Kast John E
• Miltich Thomas P
• Munns Gordon O
• Roles Randy S
• Schmidt Craig L
• Viavattine Joseph J
• Nielsen Christian S
• Tamirisa Prabhakar A
• Chasensky Anthony M
• Reiterer Markus W
• Paidosh Chris J
• Robinson Reginald D
• Li Bernard Q
• Scott Erik R
• Falkner Phillip C
• Wei Xuan K
• Bonde Eric H
• Dinsmoor David A
• Bourget Duane L
• Pape Forrest C M
• Molnar Gabriela C
• Anderson Joel A
• Ebert Michael J
• Stone Richard T
• Kelley Shawn C
• Roddy Stephen J
• Denison Timothy J
• Smith Todd V

Classifications

• A61N1/02 Primary

  Details · CPC title

• A61B17/00234

  for minimally invasive surgery (A61B17/0218, A61B17/0469, A61B17/12013, A61B17/1285, A61B17/29, A61B17/320016 take precedence) · CPC title

• A61N1/05

  for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) · CPC title

• A61N1/0551

  Spinal or peripheral nerve electrodes · CPC title

• A61N1/36007

  of urogenital or gastrointestinal organs, e.g. for incontinence control · CPC title